Editorial policy
One standard, applied the same way to every company, written down before we look at which of them pays us. This page says what that standard is, what will move a grade, and what will not — including money.
Current as of September 3, 2026, the date of the most recent price check on this site.How a company ends up on this site
We cover the seller, not the molecule. A company qualifies if it sells GLP-1 prescriptions or research peptides to US patients through telehealth and publishes enough for a reader to act on — or hides enough that somebody should say so.
Which of those companies we get to first is a question of reach: the ones people are actually searching for and paying, and the ones whose pricing is hardest to pin down, go before the ones nobody is asking about. What decides the order is never whether a company has approved us for a program. 28 companies are published so far, and 6 of them pay us a commission — the disclosure page keeps that ledger, counted rather than described.
We do not take suggestions in exchange for anything, we do not run paid inclusion, and a company cannot buy its way onto the site or off it. A company that asks to be removed stays, with its grade, as long as what we published about it is accurate.
Independence, and the order it depends on
The grade goes first. We read a company’s pages, source its prices, write the letter and the reason for it, and only afterward does anyone establish whether we have an approved affiliate program with that company. Those are two separate pieces of code, not two steps in one, which is what makes the sequence real rather than a promise.
Nothing is for sale here: not a grade, not a position on a page, not a mention, not a removal. Nobody has ever been offered one and nobody will be. If a company drops its program tomorrow, its grade does not move. The disclosure page is where the money side is set out in full.
What has to be true before a review ships
- A price we read ourselves. From the company’s own page, quoted verbatim, with the URL and the date we read it. Never a number from an aggregator, a press release, or another site.
- Never a homepage. A price read off a bare domain root is not sourced, and the build rejects it.
- The intake, when the page hides the number. “No published price” is almost never true; it usually means nobody finished the form. So when a company hides the real figure behind its signup, we finish the signup — dummy details, no card — and the review says the number was not published. 8 of the 150 prices here came out that way, and each records how many steps in the figure appeared.
- Month to month, not the advertised number. The headline figure in this market is usually a prepaid annual rate divided by twelve. We publish what you pay if you cancel after a month.
- A verdict that opens with the price. Not with context, not with a definition, and not with the story of how we found it.
The scale
Five outcomes, no half-letters hiding under a decimal. Every grade on this site shows the letter, the word, and a glyph together — color never carries a grade on its own, because under some forms of color blindness our amber and our green are too close to separate by hue.
| Grade | Reads as |
|---|---|
| A | Verified |
| B | Minor gap |
| C | Caveat |
| F | Fail |
| — | Not disclosed |
A dash is not a soft C. It means the company withheld something we needed, and we are not rounding that up to make a page look tidier. How we grade goes through each letter.
What moves a grade
| This does | What we do about it |
|---|---|
| A price change | Re-read the source page, re-date the capture, and re-run the grade against the new number. Every page carrying the old figure is swept, not just the one where it was spotted. |
| A disclosure change | A company that starts naming its pharmacy, its prescribers, or the states it serves can move up. One that stops publishing something it used to publish moves down. |
| A regulatory action | Matched to the company by domain and address, never by a similar name. It is disclosed on the review. It is a fact about the company, not an automatic failing grade. |
| A correction we verify | From anyone, including the company. We check it against their own pages first — a “we start at $X” note is usually an introductory rate, not the month-to-month price this site publishes. |
What never moves a grade
- An affiliate commission, an approval, or the size of a payout.
- A request, an offer, or a complaint from the company.
- How a provider ranks on another site.
- How much traffic a page gets or how well it converts.
Presentation is a different question from grading, and we keep the two apart deliberately. Which partner appears in a side card can depend on commercial factors; what letter a company carries cannot.
Corrections
When a fact changes, we fix every surface that carries it, and the page shows the new read date. We do not quietly edit a number and leave the old date standing.
Send corrections to desk@telehealthgraded.com or through the contact page, which sets out what makes a correction actionable.
What we refuse to publish
- A medical reviewer. Nobody at Telehealth Graded holds a license, and inventing a clinician to make a page look authoritative is the single worst thing a site in this category can do.
- Customer testimonials or star ratings. We have collected none, and the grade is editorial, not crowd-sourced.
- Urgency mechanics — countdowns, fake scarcity, expiring offers we don’t control.
- A number whose source we cannot show you, or a claim about what a company does not publish that we have not gone and checked.
Nothing here is medical advice; the limits of that are on the terms page, and about us covers who writes this and how it is funded.